EURO-VOYAGE: Effectiveness and safety of ipilimumab (IPI) administered during a European Expanded Access Programme (EAP) in patients with advanced melanoma (MEL)
Title:
EURO-VOYAGE: Effectiveness and safety of ipilimumab (IPI) administered during a European Expanded Access Programme (EAP) in patients with advanced melanoma (MEL)
Author:
Ascierto, P. Bastholt, L. Mohr, P. Hoeller, C. Robert, C. Larkin, J. Dummer, R. Ekbom, A. Chiarion-Sileni, V. Dutriaux, C. Mortier, L. Neyns, B. Nyakas, M. Garbe, C. Baurain, J.F. Kruse, V. Svane, I.M. Alfaya, L. Ciria, C. Blank, C.